Synlogic, Inc. (SYBX) Financials

SYBX Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2024 20.8 million 7.6 million
June 30, 2024 21.6 million 5.7 million
March 31, 2024 36.1 million 22.7 million
Dec. 31, 2023 75.6 million 32.9 million

SYBX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2024 -649000 102000
June 30, 2024 -14.6 million 498000
March 31, 2024 -15.8 million 2.2 million
Dec. 31, 2023 -5.6 million 803000

SYBX Net Income

No data available :(

SYBX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2024 19.4 million - -
June 30, 2024 20.0 million - -
March 31, 2024 32.3 million 23.6 million 14.5 million
Dec. 31, 2023 47.7 million 25.0 million 17.3 million

SYBX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2024 ?
June 30, 2024 12.4 million
March 31, 2024 12.1 million
Dec. 31, 2023 8.5 million

SYBX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2024 - 713000 1.2 million -
June 30, 2024 381000 2.2 million 1.2 million -
March 31, 2024 395000 7.3 million 1.9 million -948000
Dec. 31, 2023 28000 10.1 million 3.3 million -

SYBX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2024 - -
June 30, 2024 - -
March 31, 2024 8000 1.3 million
Dec. 31, 2023 2.8 million 1.3 million

SYBX

Price: $1.20

52 week price:
0.54
1.87

Earnings Per Share: -0.26 USD

P/E Ratio: -2.31

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 107155

Ebitda: -10.6 million

Market Capitalization: 13.7 million

Links: